1. Characteristics, clinical outcome, and prognostic significance of IDH mutations in AML. Issue 8 (August 2015) Authors: DiNardo, Courtney D.; Ravandi, Farhad; Agresta, Sam; Konopleva, Marina; Takahashi, Koichi; Kadia, Tapan; Routbort, Mark; Patel, Keyur P.; Mark Brandt; Pierce, Sherry; Garcia‐Manero, Guillermo; Cortes, Jorge; Kantarjian, Hagop Journal: American journal of hematology Issue: Volume 90:Issue 8(2015:Aug.) Page Start: 732 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Isocitrate Dehydrogenase 1 (IDH1) Mutation in Breast Adenocarcinoma Is Associated With Elevated Levels of Serum and Urine 2-Hydroxyglutarate. (23rd April 2014) Authors: Fathi, Amir T.; Sadrzadeh, Hossein; Comander, Amy H.; Higgins, Michaela J.; Bardia, Aditya; Perry, Ashley; Burke, Meghan; Silver, Regina; Matulis, Christina R.; Straley, Kimberly S.; Yen, Katharine E.; Agresta, Sam; Kim, Hyeryun; Schenkein, David P.; Borger, Darrell R. Journal: Oncologist Issue: Volume 19:Number 6(2014) Page Start: 602 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Isocitrate Dehydrogenase 1 (IDH1) Mutation in Breast Adenocarcinoma Is Associated With Elevated Levels of Serum and Urine 2‐Hydroxyglutarate. (23rd April 2014) Authors: Fathi, Amir T.; Sadrzadeh, Hossein; Comander, Amy H.; Higgins, Michaela J.; Bardia, Aditya; Perry, Ashley; Burke, Meghan; Silver, Regina; Matulis, Christina R.; Straley, Kimberly S.; Yen, Katharine E.; Agresta, Sam; Kim, Hyeryun; Schenkein, David P.; Borger, Darrell R. Journal: Oncologist Issue: Volume 19:Number 6(2014) Page Start: 602 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Isocitrate dehydrogenase 1 and 2 mutations, 2‐hydroxyglutarate levels, and response to standard chemotherapy for patients with newly diagnosed acute myeloid leukemia. Issue 4 (13th November 2018) Authors: Brunner, Andrew M.; Neuberg, Donna S.; Wander, Seth A.; Sadrzadeh, Hossein; Ballen, Karen K.; Amrein, Philip C.; Attar, Eyal; Hobbs, Gabriela S.; Chen, Yi‐Bin; Perry, Ashley; Connolly, Christine; Joseph, Christelle; Burke, Meghan; Ramos, Aura; Galinsky, Ilene; Yen, Katharine; Yang, Hua; Straley, ... Journal: Cancer Issue: Volume 125:Issue 4(2019) Page Start: 541 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase 1 Single‐ and Multiple‐Ascending‐Dose Randomized Studies of the Safety, Pharmacokinetics, and Pharmacodynamics of AG‐348, a First‐in‐Class Allosteric Activator of Pyruvate Kinase R, in Healthy Volunteers. Issue 2 (9th August 2018) Authors: Yang, Hua; Merica, Elizabeth; Chen, Yue; Cohen, Marvin; Goldwater, Ronald; Kosinski, Penelope A.; Kung, Charles; Yuan, Zheng (Jason); Silverman, Lee; Goldwasser, Meredith; Silver, Bruce A.; Agresta, Sam; Barbier, Ann J. Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 2(2019) Page Start: 246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗